Rezultati pretrage - Mathijs C. Bunck

  • Prikaz rezultata 1 – 18 od 18
Detaljiziraj rezultate
  1. 1
    Fifty‐ two—Week Treatment With Diet and Exercise Plus Transdermal Testosterone Reverses the Metabolic Syndrome and Improves Glycemic Control in Men With Newly Diagnosed Type 2 Diabetes and Subnormal Plasma Testosterone

    Fifty‐ two—Week Treatment With Diet and Exercise Plus Transdermal Testosterone Reverses the Metabolic Syndrome and Improves Glycemic Control in Men With Newly Diagnosed Type 2 Diab... od Armin E. Heufelder, Farid Saad, Mathijs C. Bunck, Louis Gooren

    Izdano 2009
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  2. 2
    Weight reduction and the impact on apnea-hypopnea index: A systematic meta-analysis

    Weight reduction and the impact on apnea-hypopnea index: A systematic meta-analysis od Atul Malhotra, Cory R. Heilmann, Kushal K. Banerjee, Julia P. Dunn, Mathijs C. Bunck, Josef Bednařík

    Izdano 2024
    Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  3. 3
    Incretin mimetics as a novel therapeutic option for hepatic steatosis

    Incretin mimetics as a novel therapeutic option for hepatic steatosis od Maarten E. Tushuizen, Mathijs C. Bunck, Petra J. W. Pouwels, Jan Hein T. van Waesberghe, Michaëla Diamant, Robert J. Heine

    Izdano 2006
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  4. 4
    Effects of Exenatide on Measures of β-Cell Function After 3 Years in Metformin-Treated Patients With Type 2 Diabetes

    Effects of Exenatide on Measures of β-Cell Function After 3 Years in Metformin-Treated Patients With Type 2 Diabetes od Mathijs C. Bunck, A. H. Corner, Björn Eliasson, Robert J. Heine, Rimma M. Shaginian, Marja‐Riitta Taskinen, Ulf Smith, Hannele Yki‐Järvinen, Michaëla Diamant

    Izdano 2011
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  5. 5
    Exenatide Affects Circulating Cardiovascular Risk Biomarkers Independently of Changes in Body Composition

    Exenatide Affects Circulating Cardiovascular Risk Biomarkers Independently of Changes in Body Composition od Mathijs C. Bunck, Michaëla Diamant, Björn Eliasson, A. H. Corner, Rimma M. Shaginian, Robert J. Heine, Marja‐Riitta Taskinen, Hannele Yki‐Järvinen, Ulf Smith

    Izdano 2010
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  6. 6
    Tirzepatide and blood pressure reduction: stratified analyses of the SURMOUNT-1 randomised controlled trial

    Tirzepatide and blood pressure reduction: stratified analyses of the SURMOUNT-1 randomised controlled trial od Harlan M. Krumholz, James A. de Lemos, Naveed Sattar, Bruno Linetzky, Palash Sharma, Casey J Mast, Nadia N. Ahmad, Mathijs C. Bunck, Adam Stefański

    Izdano 2024
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  7. 7
    Pancreatic Fat Content and β-Cell Function in Men With and Without Type 2 Diabetes

    Pancreatic Fat Content and β-Cell Function in Men With and Without Type 2 Diabetes od Maarten E. Tushuizen, Mathijs C. Bunck, Petra J. W. Pouwels, Saskia Bontemps, Jan Hein T. van Waesberghe, Roger K. Schindhelm, Andrea Mari, Robert J. Heine, Michaëla Diamant

    Izdano 2007
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  8. 8
    Tirzepatide Reduces 24-Hour Ambulatory Blood Pressure in Adults With Body Mass Index ≥27 kg/m <sup>2</sup> : SURMOUNT-1 Ambulatory Blood Pressure Monitoring Substudy

    Tirzepatide Reduces 24-Hour Ambulatory Blood Pressure in Adults With Body Mass Index ≥27 kg/m <sup>2</sup> : SURMOUNT-1 Ambulatory Blood Pressure Monitoring Substudy od James A. de Lemos, Bruno Linetzky, Carel W. le Roux, Luke J. Laffin, Wanpen Vongpatanasin, L. Fan, Andrea Hemmingway, Nadia N. Ahmad, Mathijs C. Bunck, Adam Stefański

    Izdano 2024
    Preuzmi cijeli tekst
    Carta
    Spremi u popis
    Spremljeno u:
  9. 9
    Tirzepatide Once Weekly for the Treatment of Obesity

    Tirzepatide Once Weekly for the Treatment of Obesity od Ania M. Jastreboff, Louis J. Aronne, Nadia N. Ahmad, Sean Wharton, Lisa Connery, Breno Edson Sendão Alves, Arihiro Kiyosue, Shuyu Zhang, Bing Liu, Mathijs C. Bunck, Adam Stefański

    Izdano 2022
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  10. 10
    Tirzepatide for the treatment of obesity: Rationale and design of the <scp>SURMOUNT</scp> clinical development program

    Tirzepatide for the treatment of obesity: Rationale and design of the <scp>SURMOUNT</scp> clinical development program od Carel W. le Roux, Shuyu Zhang, Louis J. Aronne, Robert F. Kushner, Ariana M. Chao, Sriram Machineni, Julia P. Dunn, Farai Chigutsa, Nadia N. Ahmad, Mathijs C. Bunck

    Izdano 2022
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  11. 11
    Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the treatment of obesity: An indirect treatment comparison

    Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the treatment of obesity: An indirect treatment comparison od Carel W. le Roux, Emily R. Hankosky, Duzhe Wang, Raleigh Malik, Maria Yu, Ana Hickey, Hong Kan, Mathijs C. Bunck, Adam Stefański, Luis-Emilio Garcı́a-Pérez, Sean Wharton

    Izdano 2023
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  12. 12
    Acute and 2-week exposure to prednisolone impair different aspects of β-cell function in healthy men

    Acute and 2-week exposure to prednisolone impair different aspects of β-cell function in healthy men od Daniël H. van Raalte, Valentina Nofrate, Mathijs C. Bunck, Thijs van Iersel, Jeroen Elassaiss Schaap, U. K. Nässander, Robert J. Heine, Andrea Mari, Wim H.A. Dokter, Michaëla Diamant

    Izdano 2010
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  13. 13
    Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial

    Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial od Thomas A. Wadden, Ariana M. Chao, Sriram Machineni, Robert F. Kushner, Jamy D. Ard, Gitanjali Srivastava, Bruno Halpern, Shuyu Zhang, Jiaxun Chen, Mathijs C. Bunck, Nadia N. Ahmad, Tammy Forrester

    Izdano 2023
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  14. 14
    Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial

    Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial od Thomas A. Wadden, Ariana M. Chao, Sriram Machineni, Robert F. Kushner, Jamy D. Ard, Gitanjali Srivastava, Bruno Halpern, Shuyu Zhang, Jiaxun Chen, Mathijs C. Bunck, Nadia N. Ahmad, Tammy Forrester

    Izdano 2024
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Errata/Corrigenda
    Spremi u popis
    Spremljeno u:
  15. 15
    Tirzepatide for the treatment of obstructive sleep apnea: Rationale, design, and sample baseline characteristics of the SURMOUNT -OSA phase 3 trial

    Tirzepatide for the treatment of obstructive sleep apnea: Rationale, design, and sample baseline characteristics of the SURMOUNT -OSA phase 3 trial od Atul Malhotra, Josef Bednařík, Sujatro Chakladar, Julia P. Dunn, Terri E. Weaver, Ronald R. Grunstein, Ingo Fietze, Susan Redline, Ali Azarbarzin, Scott A. Sands, Richard J. Schwab, Mathijs C. Bunck

    Izdano 2024
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  16. 16
    One-Year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients

    One-Year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients od Mathijs C. Bunck, Michaëla Diamant, A. H. Corner, Björn Eliasson, Jaret Malloy, Rimma M. Shaginian, Wei Deng, David M. Kendall, Marja‐Riitta Taskinen, Ulf Smith, Hannele Yki‐Järvinen, Robert J. Heine

    Izdano 2009
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  17. 17
    Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity

    Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity od Louis J. Aronne, Naveed Sattar, Deborah B. Horn, Harold Bays, Sean Wharton, Wen‐Yuan Lin, Nadia N. Ahmad, Shuyu Zhang, Ran Liao, Mathijs C. Bunck, Irina Jouravskaya, Madhumita A. Murphy, Jose Osvaldo Fretes, Maria Jimena Coronel, Lucas L Gutnisky, Gustavo Frechtel, Elizabeth Gelersztein, Diego Aizenberg, Natacha Maldonado, Márcio Pereira, Queulla G Santos, Camila Calil Salim, Luís Henrique Santos Canani, Bruno Halpern, Luis AT Russo, Joselita Bodart, Danilo V Neto, Gustavo Augusto, Silmara Leite, Yi‐Ching Yang, Wen‐Yuan Lin, Chien‐Ning Huang, Kuo‐Chin Huang, David Fitz-Patrick, Cindy HT Pau, Phillip D. Toth, G.H. Freeman, Donald F Gardner, Alan Wynne, Juan Loy, Deborah B. Horn, Purvi Mehra, Stacey Layle, James H. Bergthold, José de Souza, Venkatesh Nadar, G Angulo, Ken Cohen, Timothy R. Smith, Louis J. Aronne, Michael G. Vaughn, Altagracia Aurora Alcantara-Gonzalez, Seth Forman, John Agaiby, S Geller, Neil J. Fraser, Robert A. Jenders, Kim Barbel-Johnson, Ronald K. Mayfield, Carl D Vance, Kevin T Prier, Alexander V. Murray, Michael Lillestol, Douglas Denham, Jean Park, E. Klein, Harold Bays, Athena Philis‐Tsimikas, Peter E Bressler, John C.H. Reed, Shamaila Aslam, Julio Rosenstock, Juan P. Frías, Leslie J. Klaff, Ronald Brazg, Martha Gomez-Cuellar, Lisa Connery, Joanna Van, Jean-Louis Sélam, John Kim, Dwight Blake, John Gabriel, Samir Arora, Michael J McCartney, Royce Keith Solano, Steven K Brodie, John Nardandrea

    Izdano 2023
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  18. 18
    Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

    Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial od W. Timothy Garvey, Juan P. Frías, Ania M. Jastreboff, Carel W. le Roux, Naveed Sattar, Diego Aizenberg, Huzhang Mao, Shuyu Zhang, Nadia N. Ahmad, Mathijs C. Bunck, Imane Benabbad, X. Zhang, Franklin Ábalos, Federico C. Pérez Manghi, Cesar Javier Zaidman, Marisa L. Vico, Diego Aizenberg, P. Costanzo, L. Serra, Ignacio MacKinnon, Miguel Nasser Hissa, Maria H Vidotti, José Francisco Kerr Saraiva, Breno B. Alves, Denise Reis Franco, Otavio Moratto, Sreenivasa Murthy, Ghanshyam Goyal, Yoshimitsu Yamasaki, Nobuyuki Sato, Satoshi Inoue, Taro Asakura, Marina V. Shestakova, Elena Khaykina, Е. А. Трошина, Н. В. Ворохобина, Ametov As, Shih‐Te Tu, Chwen-Yi Yang, I‐Te Lee, Chien‐Ning Huang, Horng‐Yih Ou, George Freeman, Sriram Machineni, Klara R. Klein, Senan Sultan, Alan A. Parsa, Juan Otero-Martinez, Alex Gonzalez, Anuj Bhargava, Susan Brian, Carlos Ince, Stephen Plantholt, Jeremy Cole, Audrey Lacour, Damaris Vega, José de Souza, Jane L. Rohlf, Roy C. St. John, Barry Horowitz, Hanid Audish, Rodolfo J. Galindo, Guillermo Umpiperrez, Jamy D. Ard, Brian R. Curtis, W. Timothy Garvey, Neil J. Fraser, Jose Mandry, Rizwana Mohseni, Ronald K. Mayfield, Talessa Powell, Carl Vance, Stephen Ong, Ana L. Lewy-Alterbaum, Alexander V. Murray, Amer Al‐Karadsheh, Tamer Yacoub, Kevin Roberts, David L. Fried, Julio Rosenstock, Bharathi Pulla, Bruce W. Bode, Juan P. Frías, Leslie J. Klaff, Ronald Brazg, Joanna Van, Anjanette Tan, Toby Briskin, Margaret Rhee, Tira Chaicha-Brom, Paul Hartley, Lazaro Nunez, Gregorio Cortes-Maisonet, Gary Soucie, Stanley H. Hsia, Thomas C. Jones

    Izdano 2023
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:

Alati za pretragu: